Avadel Pharmaceuticals PLC Sponsored ADR Stock

$9.39

0.43% yesterday

Nasdaq, May 20, 07:46 pm CET

ISIN

US05337M1045

Symbol

AVDL

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Medical specialties

Overview Dividends Analysts Charts News Strategies

Avadel Pharmaceuticals PLC Sponsored ADR Stock price

$9.37

+1.31 16.25% 5Y

Nasdaq, Closing price Tue, May 20 2025

+0.02 0.21%

ISIN

US05337M1045

Symbol

AVDL

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Medical specialties

Key metrics

Market capitalization	$906.44m
Enterprise Value	$878.37m
P/E (TTM) P/E ratio	negative
EV/FCF (TTM) EV/FCF	negative
EV/Sales (TTM) EV/Sales	4.52
P/S ratio (TTM) P/S ratio	4.66
P/B ratio (TTM) P/B ratio	12.22
Revenue growth (TTM) Revenue growth	252.64%
Revenue (TTM) Revenue	$194.45m
EBIT (operating result TTM) EBIT	$-19.37m
Free Cash Flow (TTM) Free Cash Flow	$-24.78m
Cash position	$66.48m
EPS (TTM) EPS	$-0.27
P/E forward	65.33
P/S forward	3.52
EV/Sales forward	3.41
Short interest	12.38%

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Get Started for Free Today

Avadel Pharmaceuticals PLC Sponsored ADR Stock Analysis

Unlock Scores for Free

??

10 Analysts have issued a Avadel Pharmaceuticals PLC Sponsored ADR forecast:

10x Buy

100%

More details on Analyst Estimates Including Price Targets

10 Analysts have issued a Avadel Pharmaceuticals PLC Sponsored ADR forecast:

Buy

100%

Analyst Estimates with Stock Price Targets

Financial data from Avadel Pharmaceuticals PLC Sponsored ADR

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Mar '25		+/- %
Revenue	194 194	253% 253% 100%
- Direct Costs	19 19	443% 443% 10%
Gross Profit	175 175	228% 228% 90%
- Selling and Administrative Expenses	175 175	0% 0% 90%
- Research and Development Expense	16 16	32% 32% 8%
EBITDA	-16 -16	88% 88% -8%
- Depreciation and Amortization	2.97 2.97	- 2%
EBIT (Operating Income) EBIT	-19 -19	86% 86% -10%
Net Profit	-26 -26	83% 83% -14%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Avadel Pharmaceuticals PLC Sponsored ADR Stock News

Positive

Seeking Alpha

●

6 days ago

Avadel Pharmaceuticals: Moving Nicely Through An 'Inflection Year'

Avadel Pharmaceuticals is gaining momentum with strong Q1 results, a key legal win, and moving swiftly to profitability. LUMRYZ, Avadel's once-daily sodium oxybate, is growing rapidly and could enter the idiopathic hypersomnia market after a favorable court ruling. Analysts remain bullish, reiterating Buy ratings and projecting significant revenue and profit growth through FY2026 as LUMRYZ adop...

Neutral

GlobeNewsWire

●

7 days ago

Avadel Pharmaceuticals Expands Leadership Team with Appointment of Susan Rodriguez as Chief Operating Officer

DUBLIN, May 13, 2025 (GLOBE NEWSWIRE) -- DUBLIN, May 13, 2025 – Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, today announced the appointment of Susan Rodriguez as Chief Operating Officer. In this newly created role, Ms. Rodriguez will lead all aspects of the Company's commercial strategy, structure, organization, an...

Neutral

GlobeNewsWire

●

8 days ago

Avadel Pharmaceuticals to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference

DUBLIN, May 13, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in a fireside chat at the H.C. Wainwright 3rd Annual BioConnect Investor Conference on Tuesday, May 20 at 12:00 p.m.

More Avadel Pharmaceuticals PLC Sponsored ADR News

Company Profile

Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. It offers Bloxiverz, Vazculep, and Akovaz. The company was founded on December 1, 2015 and is headquartered in Dublin, Ireland.

Head office	Ireland
CEO	Gregory Divis
Employees	188
Founded	2015
Website	www.avadel.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now